RxDoctor Payments Data

Diane Heaton, MD

Radiation Oncology · Tulsa, OKNPI 1629067962

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $29,030 of the $35,728 with a category attached, or 81.3%. Siemens Medical Solutions USA, Inc. accounts for 65.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $8,762 and has fallen 66.6% since, to $2,925 in 2025. Among radiation oncology clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$35,728in general payments, 2019–2025

Across 56 payments — averaging $638.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Siemens Medical Solutions USA, Inc.$23K
  • Varian Medical Systems, Inc.$11K
  • AstraZeneca$356
  • Boston Scientific$247
  • Novocure Inc.$190
  • Covidien LP$128
  • plus $457 from 6 others
$101,250in research payments, 2019–2025

Across 3 payments — averaging $33,750 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Siemens Medical Solutions USA, Inc.$101K

What the payments were for

  • Consulting fees$4,20012%
  • Speaking & faculty fees$29,03081%
  • Travel & lodging$3351%
  • Food & beverage$2,0926%
  • Education$720%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$35,728 in reported general payments places this provider in the 95th percentile of 43 radiation oncology providers in Oklahoma.

See all radiation oncology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$708,082
Medicare patients
274
Services billed
5,366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl12$17,457
MyrbetriqMirabegron13$5,574
Pentoxifylline111$3,072
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$916
Tamsulosin Hcl66$840
Nystatin32$734
Carbamazepine38$669
Megestrol Acetate11$655
Lidocaine Hcl ViscousLidocaine Hcl41$593
Methylprednisolone45$309
Gabapentin14$290
Ondansetron Hcl16$234
Montelukast Sodium14$195
Amitriptyline Hcl11$172
Fluconazole11$123

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →